TACR1 and HIV infectious disease: Using a large donor cohort we demonstrated inhibition of HIV infection in MDM ex vivo at a concentration of ~5 μM from 125 depressed and non-depressed HIV negative individuals which is line with projected free drug trough concentrations [42] required to elicit 100 % NK1R occupancy.